Morton Brown Family Wealth’s Gilead Sciences GILD Stock Holding History

Morton Brown Family Wealth’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$52.4K	Buy	414 +25	+6%	+$3.29K	0.01%	120
2026 Q1	$54.2K	Buy	389 +2	+0.5%	+$280	0.01%	115
2025 Q4	$47.4K	Buy	387 +3	+0.8%	+$365	0.01%	114
2025 Q3	$42.6K	Buy	384 +3	+0.8%	+$341	0.01%	116
2025 Q2	$42.3K	Buy	381 +2	+0.5%	+$213	0.01%	116
2025 Q1	$42.4K	Buy	379 +3	+0.8%	+$310	0.01%	110
2024 Q4	$34.7K	Buy	+376	New	+$33.9K	0.01%	121
2022 Q4	–	Sell	-142	Closed	-$9K	–	189
2022 Q3	$9K	Buy	142 +102	+255%	+$6.43K	0.01%	114
2022 Q2	$2K	Buy	+40	New	+$2.48K	﹤0.01%	195

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Morton Brown Family Wealth's GILD Position: Q2 2026 in Review

Morton Brown Family Wealth increased its Gilead Sciences (GILD) stake by 6.4% in Q2 2026, buying an estimated $3.29K and bringing the position to 414 shares worth $52.4K. The position accounts for 0.01% of the portfolio, ranked #120.

Morton Brown Family Wealth first reported a position in GILD in Q2 2022 and has held it in 9 quarters since. The position peaked at $54.2K in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Morton Brown Family Wealth held 414 shares of Gilead Sciences worth $52.4K as of Q2 2026.
Morton Brown Family Wealth bought 25 Gilead Sciences shares in Q2 2026, an estimated $3.29K.
Gilead Sciences made up 0.01% of Morton Brown Family Wealth's portfolio in Q2 2026, its #120 holding.
Morton Brown Family Wealth first reported a position in Gilead Sciences in Q2 2022 and has held it in 9 quarters since.
Morton Brown Family Wealth's Gilead Sciences position peaked at $54.2K in Q1 2026.
2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Morton Brown Family Wealth's 13F filing for Q2 2026, filed 21 Jul 2026.